OLAPARIB

7433 reported adverse events

Drug classes: Poly(ADP-Ribose) Polymerase Inhibitor [EPC]

These side effects are most commonly reported by patients taking OLAPARIB:

# Side effect Count
0 DEATH 1781
1 MALIGNANT NEOPLASM PROGRESSION 1104
2 NAUSEA 793
3 ANAEMIA 702
4 FATIGUE 589
5 OFF LABEL USE 499
6 VOMITING 315
7 DIARRHOEA 240
8 DECREASED APPETITE 224
9 MYELODYSPLASTIC SYNDROME 222
See all common reactions for OLAPARIB

OLAPARIB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 BRCA2 GENE MUTATION 15 0.3261
1 PROTEIN INTOLERANCE 2 0.2500
2 ERYTHROBLAST COUNT ABNORMAL 2 0.2000
3 OVARIAN CANCER RECURRENT 98 0.1617
4 MALIGNANT NEOPLASM OF UTERINE ADNEXA 2 0.1333
5 ARTERIOENTERIC FISTULA 2 0.1250
6 BRCA1 GENE MUTATION 4 0.1250
7 CARBOHYDRATE ANTIGEN 125 2 0.1176
8 OVARIAN EPITHELIAL CANCER RECURRENT 4 0.1111
9 MUSCULOSKELETAL TOXICITY 8 0.1111
See all enriched reactions for OLAPARIB